Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
PRNewswire - Thursday October 29, 1998
Speaking today at the American Academy of Dermatology's Derm Update '98, Marcus A. Conant, MD, Clinical Professor of Dermatology, University of California, San Francisco, CA, discussed the promising new results in the treatment of HIV-related skin diseases.
The association of herpes zoster, oral candidiasis, oral hairy leukoplakia and molluscum contagiosum with HIV was so significant that these cutaneous conditions were used as signs of disease progression in early clinical trials of antiviral medications. While these dermatological conditions are not as precise as the CD4 count in measuring the level of immunodeficiency, they are of great value in under-developed countries where expensive laboratory tests are not available.
The good news is that with the introduction of combination antiretroviral therapy, patients' viral loads (the amount of HIV in the body) dropped to levels below the level of detection. In addition, the patients' disease did not progress or show signs of further complications. In many cases, general well being improved and CD4 counts began to rise. At the same time, patients with Kaposi's sarcoma showed almost immediate arrest in the rate of progression of their cancer, with progressive overall improvement in the disease when the viral load remained below the level of detection.
Eosinophilic folliculitis may initially flare with aggressive therapy, but it also clears as the CD4 count rises above 100. Molluscum contagiosum becomes easily manageable and candida and oral hairy leukoplakia clear.
"Thus, in the second phase of the AIDS epidemic, the treatment of choice for most HIV-associated skin diseases including Kaposi's sarcoma is aggressive antiretroviral therapy and maintenance of the viral load below the level of detection," Dr. Conant said.
The American Academy of Dermatology is the largest medical society representing physicians who specialize in treating skin, hair and nail conditions.
REFERENCE NOTE:
Conant, M.A., M.D.; et al.; Anonymous HIV Testing Using Home Collection and Telemedicine Counseling, Archives of Internal Medicine, 1997, Vol. 157, pp. 309-314.
Conant, M.A., M.D.; et al.; Reduction of Kaposi's Sarcoma Lesions following Treatment of AIDS with Ritonavir, Journal of AIDS, August 1997, pp. 1300-1301.
Conant, M.A., M.D.; Lessons from the AIDS Epidemic, Cutaneous Infection and Therapy, 1997, pp. 217-222.
SOURCE: American Academy of Dermatology
981029
PR981018
Copyright © 1998 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .